Suresh Mahabhashyam is the Vice President of Clinical Development at Corvus Pharmaceuticals, specializing in immuno-oncology. His career includes leadership roles in drug safety and pharmacovigilance at Infinity Pharmaceuticals and Alexion. He earned his M. B. B. S. from Bangalore Medical College and an MPH from UNT Health Fort Worth.
He has presented his research on adenosine receptor antagonists at industry congresses, highlighting his deep expertise in novel cancer therapy pathways.
Read the full overview →Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.